<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Invitrogen Corporation (Web)</title><link>http://www.zibb.com/all/theme/cq/Invitrogen+Corporation</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Invitrogen+Corporation" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Wed, 25 Nov 2009 06:00:31 GMT</pubDate><lastBuildDate>Wed, 25 Nov 2009 06:00:31 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Invitrogen Corporation (Web)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Invitrogen+Corporation</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>DLA Piper | ニュース | DLA Piper advises Invitrogen on $6.7 billion m...
      </title><link>http://www.dlapiper.com/ja/invitrogen_merger</link><description>DLA Piper advised Invitrogen Corporation in its proposed $6.7 billion merger with Applera Corporation. The deal will create one of the world’s leading biotechnology companies, to be named Applied Biosystems, with expected annual sales of approximately $3.5 billion.</description><guid>http://www.dlapiper.com/ja/invitrogen_merger</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.dlapiper.com" /></item><item><title>Invitrogen Corporation Company Details</title><link>http://www.zibb.com/all/theme/cq/Invitrogen+Corporation</link><description>DLA Piper advised Invitrogen Corporation in its proposed $6.7 billion merger with Applera Corporation. The deal will create one of the world’s leading biotechnology companies, to be named Applied Biosystems, with expected annual sales of approximately $3.5 billion. http://www.dlapiper.</description><guid>http://www.zibb.com/all/theme/cq/Invitrogen+Corporation</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.zibb.com" /></item><item><title>T-Taq™ DNA Polymerase</title><link>http://www.transgenomic.com/pd/pcramp/Ttaq.asp</link><description>Transgenomic Taq DNA polymerase (T-Taq) is a recombinant, thermostable, 94-kDa DNA polymerase encoded in Escherichia coli by a modified form of a DNA polymerase gene from Thermus aquaticus.</description><guid>http://www.transgenomic.com/pd/pcramp/Ttaq.asp</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.transgenomic.com" /></item><item><title>LanthaScreen™ Tyrosine Kinase assay PHERAstar</title><link>http://www.bmg-labtechnologies.com/application-notes/time-resolved-fluorescence/tr-fret-tyrosine-kinase-150.cfm</link><description>Introduction Tyrosine kinases (TKs) are a diverse family of enzymes that under specific signaling conditions phosphorylate proteins on the amino acid tyrosine.</description><guid>http://www.bmg-labtechnologies.com/application-notes/time-resolved-fluorescence/tr-fret-tyrosine-kinase-150.cfm</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.bmg-labtechnologies.com" /></item><item><title>Invitrogen - P450 Profiling Service</title><link>http://www.invitrogen.com/content.cfm?pageid=11813</link><description>You have requested a page which contains some regionally specific content. Please select a country now, so we can better serve you with the most accurate content available in your area.</description><guid>http://www.invitrogen.com/content.cfm?pageid=11813</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.invitrogen.com" /></item><item><title>BioProcessors</title><link>http://www.bioprocessors.com/n-20.htm</link><description>Invitrogen Adds Bioprocessors’ Simcell™ High Throughput Automated Cell Culture Microbioreactor System For Process Development Services (June 30, 2006)</description><guid>http://www.bioprocessors.com/n-20.htm</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.bioprocessors.com" /></item><item><title>European Distribution Strategy Review by Supply Chain Planning Lt...
      </title><link>http://www.scp-uk.co.uk/invitrogen.html</link><description>the brief - following Invitrogen's merger with Life Technologies, the company were considering their options for distribution of product from the combined organisations to their customers in Europe and Scandinavia.</description><guid>http://www.scp-uk.co.uk/invitrogen.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.scp-uk.co.uk" /></item><item><title>CAjobs</title><link>http://www.financialjobs.com/cajobs.htm</link><description>FEATURED JOBS THE SHORT LIST: EXPAND THIS PAGE &amp; CLICK ON THE JOBS BELOW FOR DIRECT CONTACT INFORMATION: (For the jobs in upper box use "Insert this job into my briefcase" top right box, and register online.) US-CA Costa Mesa, INSTRUCTOR, ACCOUNTING, Orange Coast College 0959 US-CA Oakland,</description><guid>http://www.financialjobs.com/cajobs.htm</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.financialjobs.com" /></item><item><title>Transgenic company : genOway - Partnership</title><link>http://www.genoway.com/partnership.htm</link><description>genOway has established successful partnerships with the following companies and research institutes and is an active member of number of research consortiums and networks.</description><guid>http://www.genoway.com/partnership.htm</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.genoway.com" /></item><item><title>Rat Cortical Stem Cell Culture Protocol</title><link>http://www.rndsystems.com/stem_cell_protocol_detail_objectname_ratcortical.aspx</link><description>NSC Base Media - Thaw the StemXVivo Serum-Free NSC Base Media at 2 - 8° C or room temperature. Aliquot any remaining thawed medium and store at -20° C. Use within 10 days when stored in the dark at 2 - 8° C.</description><guid>http://www.rndsystems.com/stem_cell_protocol_detail_objectname_ratcortical.aspx</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.rndsystems.com" /></item><item><title>Press Release - Invitrogen Completes Acquisition Of Sentigen Hold...
      </title><link>http://www.cmt-inc.net/pr_Invitrogen_061201.html</link><description>Carlsbad, Calif., Dec. 1, 2006 - Invitrogen Corporation (Nasdaq:IVGN), a global leader in life sciences, today announced it has completed its acquisition of Sentigen Holding Corp. in a cash transaction at a price of $3.37 per share, or approximately $25.9 million.</description><guid>http://www.cmt-inc.net/pr_Invitrogen_061201.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.cmt-inc.net" /></item><item><title>Plexxikon - News</title><link>http://www.plexxicon.com/pr-040605.html</link><description>Berkeley, CA. - April 6, 2005 - Plexxikon Inc. today announced an agreement under which Invitrogen Corporation will profile Plexxikon's proprietary kinase inhibitor libraries.</description><guid>http://www.plexxicon.com/pr-040605.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.plexxicon.com" /></item><item><title>COGITA® - TAKE A LOOK INSIDE NOW</title><link>http://www.cogita.co.nz/take-a-look-inside-now.html</link><description>Invitrogen helps researchers to move through their experiments more efficiently, resulting in a better understanding of disease and, ultimately, improved therapies. Supporting the scientists who take a look inside is just what Invitrogen does.</description><guid>http://www.cogita.co.nz/take-a-look-inside-now.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.cogita.co.nz" /></item><item><title>Stedim Biosystems Corporate Partnerships Invitrogen</title><link>http://www.stedim.com/comp_invitrogen.php</link><description>Invitrogen’s GIBCO™ BioProduction business, the global leader in cell culture products and services, offers patented Advanced Granulation Technology™ (AGT™) media in a complete and easy-to use granular format.</description><guid>http://www.stedim.com/comp_invitrogen.php</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.stedim.com" /></item><item><title>New</title><link>http://www.precastgels.com/novex.htm</link><description>The XCELL Surelock (TM) Apparatus above is sold by Invitrogen, who acquired Novex Corp. This unit accepts the Jule Precast Gels made in plastic cassettes.</description><guid>http://www.precastgels.com/novex.htm</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.precastgels.com" /></item><item><title>Invitrogen - Analyst News | newratings.com</title><link>http://www.newratings.com/headlines/Invitrogen_US46185R1005.html</link><description>Copyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.</description><guid>http://www.newratings.com/headlines/Invitrogen_US46185R1005.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.newratings.com" /></item><item><title>Invitrogen Corp Share Chart. IVR Historical Graphs. Techncial ana...
      </title><link>http://www.lse.co.uk/ShareChart.asp?ShareChart=IVR</link><description>Click Here Click Here Life Style Extra - Finance, News &amp; Entertainment Google Web www.lse.co.uk Life Style Extra Lines Home | Finance | News | Lifestyle | Chat Forums new - Life Style Extra Chat Forums! | Contact Register / Login Life Style Extra Lines 30 December 2006 - 03:34:23 BST Home : Finance</description><guid>http://www.lse.co.uk/ShareChart.asp?ShareChart=IVR</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.lse.co.uk" /></item><item><title>The Process RD Information Portal - Invitrogen Introduces Omnia™ ...
      </title><link>http://www.processdevelopment.net/index.aspx?ID=72690</link><description>Invitrogen Corporation has announced the launch of its Omnia™ Kinase Assays for the rapid, homogenous and sensitive detection of enzymatic activity under physiological ATP concentrations. Scientists can mix reagents, read real-time fluorescent signals and get results in under an hour.</description><guid>http://www.processdevelopment.net/index.aspx?ID=72690</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.processdevelopment.net" /></item><item><title>The Biomolecular and High Throughput Screening Information Portal...
      </title><link>http://www.htscreening.net/index.aspx?ID=66354</link><description>Invitrogen Corporation and the Fred Hutchinson Cancer Research Center have announced they have entered into a multi-year collaborative research program for the development of diagnostics and screening tools for cancer.</description><guid>http://www.htscreening.net/index.aspx?ID=66354</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.htscreening.net" /></item><item><title>Invitrogen Acquires Quantum Dot and BioPixels, Adding Nanotechnol...
      </title><link>http://www.nanotechwire.com/news.asp?nid=2398</link><description>Invitrogen Corporation, a leading life science company providing innovative technologies to support disease research, announced the acquisitions of Quantum Dot Corporation and the BioPixels business unit of BioCrystal, Ltd. and the early closing of the Biosource International, Inc. acquisition.</description><guid>http://www.nanotechwire.com/news.asp?nid=2398</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.nanotechwire.com" /></item><item><title>Biosource International Catalog</title><link>http://www.biosource.com/content/invitrogenEquiv.asp</link><description>BioSource, including the Biofluids sera and media division, was recently acquired by Invitrogen Corporation. Consequently, the Biofluids' sera and media division have been consolidated into Invitrogen's GIBCO sera and media division.</description><guid>http://www.biosource.com/content/invitrogenEquiv.asp</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.biosource.com" /></item><item><title>Invitrogen Corporation - IVGN - Annual Report - Market Research R...
      </title><link>http://www.researchandmarkets.co.uk/reportinfo.asp?report_id=56713</link><description>Research and Markets Annual Reports Service provides you with quick access to annual accounts and other information on selected companies. The Annual Report Service is the most complete and up-to-date listing of Annual Reports, and related financial reports online today.</description><guid>http://www.researchandmarkets.co.uk/reportinfo.asp?report_id=56713</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.researchandmarkets.co.uk" /></item><item><title>California Biotech Law Blog: Invitrogen Distinguished Lecture</title><link>http://www.californiabiotechlaw.com/archives/77338-print.html</link><description>San Diego Marriott - Del Mar. The speaker will be Zhu Chen, Ph.D, Vice President of the Chinese Academy of Sciences. Dr.</description><guid>http://www.californiabiotechlaw.com/archives/77338-print.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.californiabiotechlaw.com" /></item><item><title>LIMS Finder: best site for laboratory informatics, LIMS products,...
      </title><link>http://www.limsfinder.com/BlogDetail.aspx?id=31733_0_3_0_C</link><description>As part of this agreement, Invitrogen will offer SciQuest’s software solution with its life sciences products and services to deliver a multi-vendor, e-procurement platform to targeted customers.</description><guid>http://www.limsfinder.com/BlogDetail.aspx?id=31733_0_3_0_C</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.limsfinder.com" /></item><item><title>Invitrogen Corporation | Nanovip.com</title><link>http://www.nanovip.com/node/912</link><description>From Argentina to Japan to New Zealand, laboratories worldwide depend on Invitrogen products. Our research and development efforts are focused on breakthrough innovations in all major areas of biological discovery, including functional genomics, proteomics, bioinformatics, and cell biology.</description><guid>http://www.nanovip.com/node/912</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate /><source url="http://www.nanovip.com" /></item></channel></rss>